Filing Flows › Omega Healthcare Investors (OHI) › Q2 2026 › vs Q2 2025
Omega Healthcare Investors (OHI) Q2 2026 vs Q2 2025 (year over year)
Omega Healthcare Investors's revenue rose $45.7M (+16%) from $283M in Q2 2025 to $328M in Q2 2026. Operating margin 100.8% against 99.6% (+1.3 pts).
Omega Healthcare Investors, Q2 2026: revenue $328M (+16% year over year), operating margin 100.8%, net earnings $363M, operating cash flow $218M. The chart draws each line against Q2 2025, the increases inside each band.
Margins
| Q2 2026 | Q2 2025 | Change | |
|---|---|---|---|
| Operating margin | 100.8% | 99.6% | +1.3 pts |
| Net margin | 110.5% | 48.4% | +62.2 pts |
| Free cash flow margin | 60.9% | 79.5% | -18.6 pts |
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $328M | $283M | $45.7M | +16% |
| Other income, net | $53.4M | −$136M | $190M | — |
| Operating profit | $331M | $281M | $49.7M | +18% |
| Pre-tax earnings | $384M | $145M | $239M | +165% |
| Net earnings | $363M | $137M | $226M | +166% |
| Minority interests | $16.8M | $3.9M | $13.0M | +334% |
| Income tax | $4.6M | $4.5M | $90K | +2% |
| Depreciation & amortization | $81.8M | $80.5M | $1.3M | +2% |
| Share-based compensation | $23.5M | $9.2M | $14.2M | +154% |
| Working capital & other | $250M | −$12.9M | $263M | — |
| Operating cash flow | $218M | $239M | −$21.5M | -9% |
| Free cash flow (OCF − capex) | $200M | $225M | −$24.8M | -11% |
| Capital expenditures | $17.9M | $14.7M | $3.3M | +22% |
Questions
How much did Omega Healthcare Investors's revenue grow year over year in Q2 2026?
Omega Healthcare Investors's revenue rose $45.7M (+16%) from $283M in Q2 2025 to $328M in Q2 2026. Operating margin 100.8% against 99.6% (+1.3 pts).